Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Consensus Rating of “Buy” from Analysts
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) have received a consensus rating of “Buy” from the eight research firms that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy […]
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) have received a consensus rating of “Buy” from the eight research firms that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy […]
